Administration of nucleoside-modified mRNA encoding broadly neutralizing antibody protects humanized mice from HIV-1 challenge

Pardi, Norbert, Secreto, Anthony J., Shan, Xiaochuan, Debonera, Fotini, Glover, Joshua, Yi, Yanjie, Muramatsu, Hiromi, Ni, Houping +9 more·2017·Nature Communications

Cited by (351)

Items 101–200 of 351

  1. Microfluidic production of mRNA-loaded lipid nanoparticles for vaccine applications
    Carolina Lopes, Joana S. Cristóvão, Vânia Silvério, Paulo Roque Lino, Pedro Fonte · 2022 · Expert Opinion on Drug Delivery
  2. Fluorinated Lipid Nanoparticles for Enhancing mRNA Delivery Efficiency
    Huipeng Zhang, Chaoyang Meng, Xuewen Yi, Jinpeng Han, Junxia Wang, Feng Liu, Qi Ling, Hongjun Li, Zhen Gu · 2024 · ACS Nano
  3. Chemically modified hCFTR mRNAs recuperate lung function in a mouse model of cystic fibrosis
    Haque, A. K. M. Ashiqul, Dewerth, Alexander, Antony, Justin S., Riethmüller, Joachim, Schweizer, Georg R., Weinmann, Petra, Latifi, Ngadhnjim, Yasar, Hanzey, Pedemonte, Nicoletta, Sondo, Elvira et al. · 2018 · Scientific Reports
  4. HIV mRNA Vaccines—Progress and Future Paths
    Zekun Mu, Barton F. Haynes, Derek W. Cain · 2021 · Vaccines
  5. Lipid Nanoparticle Delivery Systems to Enable mRNA-Based Therapeutics
    Sean C. Semple, Robert D. Leone, Christopher Barbosa, Ying K. Tam, Paulo J.C. Lin · 2022 · Pharmaceutics
  6. Targeted lipid nanoparticles for RNA therapeutics and immunomodulation in leukocytes
    Nuphar Veiga, Yael Diesendruck, Dan Peer · 2020 · Advanced Drug Delivery Reviews
  7. In Vivo Delivery of Nucleic Acid-Encoded Monoclonal Antibodies
    Ami R. Patel, Mamadou A. Bah, David B. Weiner · 2020 · BioDrugs
  8. mRNA vaccines: The future of prevention of viral infections?
    Piotr Rzymski, Agnieszka Szuster‐Ciesielska, Tomasz Dzieciątkowski, Willis Gwenzi, Andrzej Fal · 2023 · Journal of Medical Virology
  9. Modular Lipid Nanoparticle Platform Technology for siRNA and Lipophilic Prodrug Delivery
    Roy van der Meel, Sam Chen, Josh Zaifman, Jayesh A. Kulkarni, Xu Ran S. Zhang, Ying K. Tam, Marcel B. Bally, Raymond Michel Schiffelers, Marco A. Ciufolini, Pieter R. Cullis et al. · 2021 · Small
  10. Size and Charge Characterization of Lipid Nanoparticles for mRNA Vaccines
    Camille Malburet, Laurent Leclercq, Jean‐François Cotte, Jérôme Thiebaud, Emilie Bazin, Marie Garinot, Hervé Cottet · 2022 · Analytical Chemistry
  11. The Delivery of mRNA Vaccines for Therapeutics
    Nitika, Jiao Wei, Ai‐Min Hui · 2022 · Life
  12. Lipid Nanoparticles: A Novel Gene Delivery Technique for Clinical Application
    Ryuichi Mashima, Shuji Takada · 2022 · Current Issues in Molecular Biology
  13. mRNA: A promising platform for cancer immunotherapy
    Byoungjae Kong, Yelee Kim, Eun Hye Kim, Jung Soo Suk, Yoosoo Yang · 2023 · Advanced Drug Delivery Reviews
  14. Ionizable Lipid Nanoparticles for mRNA Delivery
    Xuefeng Tang, Ying Zhang, Xiaojun Han · 2023 · Advanced NanoBiomed Research
  15. Current and Future PrEP Medications and Modalities: On-demand, Injectables, and Topicals
    Matthew R. Beymer, Ian W. Holloway, Craig Pulsipher, Raphael J. Landovitz · 2019 · Current HIV/AIDS Reports
  16. Advanced delivery systems for peptide antibiotics
    Angela Cesaro, Shuang‐Zhe Lin, Norbert Pardi, César de la Fuente‐Núñez · 2023 · Advanced Drug Delivery Reviews
  17. Nucleoside-modified VEGFC mRNA induces organ-specific lymphatic growth and reverses experimental lymphedema
    Dániel Szõke, Gábor Kovács, Éva Kemecsei, László Bálint, Kitti Ajtay, Petra Aradi, Andrea Styevkóné Dinnyés, Barbara L. Mui, Ying K. Tam, Thomas D. Madden et al. · 2021 · Nature Communications
  18. Lipid nanoparticle-encapsulated mRNA antibody provides long-term protection against SARS-CoV-2 in mice and hamsters
    Yong‐Qiang Deng, Na-Na Zhang, Yifei Zhang, Xia Zhong, Sue Xu, Hongying Qiu, Tiecheng Wang, Hui John Zhao, Chao Hui ZHOU, Shulong Zu et al. · 2022 · Cell Research
  19. Therapeutic mRNA delivery to leukocytes
    Yasmin Granot-Matok, Edo Kon, Niels Dammes, Gilad Mechtinger, Dan Peer · 2019 · Journal of Controlled Release
  20. Self-assembly of peptide nanocapsules by a solvent concentration gradient
    H.P. Li, Xuliang Qian, Harini Mohanram, Xiao Han, Huitang Qi, Guijin Zou, Fenghou Yuan, Ali Miserez, Tian Liu, Qing Kun Yang et al. · 2024 · Nature Nanotechnology
  21. Cholesterol‐Amino‐Phosphate (CAP) Derived Lipid Nanoparticles for Delivery of Self‐Amplifying RNA and Restoration of Spermatogenesis in Infertile Mice
    Shi Du, Wenqing Li, Yuebao Zhang, Yonger Xue, Xucheng Hou, Jingyue Yan, Jeffrey K. J. Cheng, Binbin Deng, David W. McComb, Jennifer S Lin et al. · 2023 · Advanced Science
  22. Development and applications of mRNA treatment based on lipid nanoparticles
    Zhe Wang, Wanting Ma, Xingxing Fu, Yanfei Qi, Yinan Zhao, Shubiao Zhang · 2023 · Biotechnology Advances
  23. Messenger RNA-Based Vaccines Against Infectious Diseases
    Alameh, Mohamad-Gabriel, Weissman, Drew, Pardi, Norbert · 2020 · Current Topics in Microbiology and Immunology
  24. State of play and clinical prospects of antibody gene transfer
    Kevin Hollevoet, Paul J. Declerck · 2017 · Journal of Translational Medicine
  25. Messenger RNA vaccines for cancer immunotherapy: progress promotes promise
    Amanda L. Huff, Elizabeth M. Jaffee, Neeha Zaidi · 2022 · Journal of Clinical Investigation
  26. Potential Applications and Perspectives of Humanized Mouse Models
    Weijian Ye, Qingfeng Chen · 2021 · Annual Review of Animal Biosciences
  27. Quantum leap of monoclonal antibody (mAb) discovery and development in the COVID-19 era
    Simone Pecetta, Oretta Finco, Anja Seubert · 2020 · Seminars in Immunology
  28. Lipid Nanoparticle Delivery System for mRNA Encoding B7H3‐redirected Bispecific Antibody Displays Potent Antitumor Effects on Malignant Tumors
    Cheng Huang, Xing Duan, Jichao Wang, Qingqing Tian, Yangmei Ren, Kepan Chen, Zongliang Zhang, Yuanyou Li, Yunyu Feng, Kunhong Zhong et al. · 2022 · Advanced Science
  29. Lipid nanoparticle-based mRNA candidates elicit potent T cell responses
    Ye Zeng, Oscar Escalona-Rayo, Renzo A. Knol, Alexander Kros, Bram Slütter · 2022 · Biomaterials Science
  30. Nanotheranostics against COVID-19: From multivalent to immune-targeted materials
    Parichehr Hassanzadeh · 2020 · Journal of Controlled Release
  31. Cationic Nanoliposomes Meet mRNA: Efficient Delivery of Modified mRNA Using Hemocompatible and Stable Vectors for Therapeutic Applications
    Tatjana Michel, Daniel Luft, Meike-Kristin Abraham, Sabrina Reinhardt, Martha L. Salinas Medina, Julia Kurz, Martin Schaller, Meltem Avci‐Adali, Christian Schlensak, Karlheinz Peter et al. · 2017 · Molecular Therapy — Nucleic Acids
  32. Tackling TNF-α in autoinflammatory disorders and autoimmune diseases: From conventional to cutting edge in biologics and RNA- based nanomedicines
    Valentina Andretto, Silvia Dusi, Serena Zilio, Mathieu Repellin, David Kryza, Stefano Ugel, Giovanna Lollo · 2023 · Advanced Drug Delivery Reviews
  33. Long-term stability and immunogenicity of lipid nanoparticle COVID-19 mRNA vaccine is affected by particle size
    Ruimeng Shi, Xueli Liu, Yajuan Wang, Meilu Pan, Shaoqin Wang, Lin Shi, Beibei Ni · 2024 · Human Vaccines & Immunotherapeutics
  34. HIV Vaccination: A Roadmap among Advancements and Concerns
    Maria Trovato, Luciana D’Apice, Antonella Prisco · 2018 · International Journal of Molecular Sciences
  35. Advancements and challenges in mRNA and ribonucleoprotein-based therapies: From delivery systems to clinical applications
    Zohre Eftekhari, Horieh Zohrabi, Akbar Oghalaie, Tahereh Ebrahimi, Fatemeh Sadat Shariati, Mahdi Behdani, Fatemeh Kazemi‐Lomedasht · 2024 · Molecular Therapy — Nucleic Acids
  36. In vivo delivery of synthetic DNA–encoded antibodies induces broad HIV-1–neutralizing activity
    Megan C. Wise, Ziyang Xu, Edgar Tello‐Ruiz, Charles Beck, Aspen Trautz, Ami R. Patel, Sarah T. C. Elliott, Neethu Chokkalingam, Sophie Kim, Melissa Kerkau et al. · 2019 · Journal of Clinical Investigation
  37. mRNA Encoding a Bispecific Single Domain Antibody Construct Protects against Influenza A Virus Infection in Mice
    Lien Van Hoecke, Rein Verbeke, Dorien De Vlieger, Heleen Dewitte, Kenny Roose, Sharon Van Nevel, Olga Krysko, Claus Bachert, Bert Schepens, Ine Lentacker et al. · 2020 · Molecular Therapy — Nucleic Acids
  38. Intravenous Delivery of RNA Encoding Anti-PD-1 Human Monoclonal Antibody for Treating Intestinal Cancer
    Lipei Wu, Weiwei Wang, Jiale Tian, Chunrun Qi, Zhengxin Cai, Wenhui Yan, Shihai Xuan, Anquan Shang · 2022 · Journal of Cancer
  39. Nanoscale delivery platforms for RNA therapeutics: Challenges and the current state of the art
    Luke H. Rhym, Daniel G. Anderson · 2022 · Med
  40. Technological advancements in antibody-based therapeutics for treatment of diseases
    Ruei‐Min Lu, Hsiao-Ling Chiang, Joyce Pei‐Yi Yuan, Hsiu-Hua Wang, Chi-Yung Chen, Sushree Shankar Panda, Kang-Hao Liang, Hung‐Pin Peng, Shih-Han Ko, Hung-Ju Hsu et al. · 2025 · Journal of Biomedical Science
  41. Monitoring Translation Activity of mRNA-Loaded Nanoparticles in Mice
    Sebastian Rosigkeit, Martin Meng, Christian R. Grunwitz, Patrícia Gomes, Andreas Kreft, Nina Hayduk, Rosario Heck, Geethanjali Pickert, Kira Ziegler, Yasmin Abassi et al. · 2018 · Molecular Pharmaceutics
  42. Mechanisms and research advances in mRNA antibody drug-mediated passive immunotherapy
    Yuxiang Zhao, Linchuan Gan, Dangjin Ke, Qi Chen, Yajuan Fu · 2023 · Journal of Translational Medicine
  43. Therapeutic synthetic and natural materials for immunoengineering
    Anna Slezak, Kevin Chang, Samir Hossainy, Aslan Mansurov, Stuart J. Rowan, Jeffrey A. Hubbell, Mustafa Ozgur Guler · 2024 · Chemical Society Reviews
  44. Lipid nanoparticle structure and delivery route during pregnancy dictate mRNA potency, immunogenicity, and maternal and fetal outcomes
    Namit Chaudhary, Alexandra N. Newby, Mariah Lynn Arral, Saigopalakrishna S. Yerneni, Samuel T. LoPresti, Rose Doerfler, Daria M. Strelkova Petersen, Catalina Montoya, Julie S. Kim, Bethany Fox et al. · 2024 · Proceedings of the National Academy of Sciences
  45. Virology—The next fifty years
    Edward Charles Holmes, Florian Krammer, Felicia D. Goodrum · 2024 · Cell
  46. Lipid Nanoparticles Potentiate CpG-Oligodeoxynucleotide-Based Vaccine for Influenza Virus
    Seiki Shirai, Meito Shibuya, Atsushi Kawai, Shigeyuki Tamiya, Lisa Munakata, Daiki Omata, Ryo Suzuki, Taiki Aoshi, Yasuo Yoshioka · 2020 · Frontiers in Immunology
  47. The Development of mRNA Vaccines for Infectious Diseases: Recent Updates
    Nitika, Jiao Wei, Ai‐Min Hui · 2021 · Infection and Drug Resistance
  48. Modulating the expression of tumor suppressor genes using activating oligonucleotide technologies as a therapeutic approach in cancer
    Georgina L. Gregory, Ian M. Copple · 2022 · Molecular Therapy — Nucleic Acids
  49. Advances in vaccine delivery systems against viral infectious diseases
    Dongyoon Kim, Yina Wu, Young Bong Kim, Yu‐Kyoung Oh · 2021 · Drug Delivery and Translational Research
  50. Lipid-nanoparticle-encapsulated mRNA vaccines induce protective memory CD8 T cells against a lethal viral infection
    Cory James Knudson, Pedro Alves-Peixoto, Hiromi Muramatsu, Colby Stotesbury, Lingjuan Tang, Paulo J.C. Lin, Ying K. Tam, Drew Weissman, Norbert Pardi, Luis J. Sigal · 2021 · Molecular Therapy
  51. The clinical impact of mRNA therapeutics in the treatment of cancers, infections, genetic disorders, and autoimmune diseases
    Roham Deyhimfar, Mehrnaz Izady, Mohammadreza Shoghi, Mohammad Hossein Kazazi, Zahra Fakhraei Ghazvini, Hojjatollah Nazari, Zahra Fekrirad, Ehsan Arefian · 2024 · Heliyon
  52. Lipid nanoparticle-based mRNA vaccines: a new frontier in precision oncology
    Eden Mariam Jacob, Jiaoti Huang, Ming Chen · 2024 · Precision Clinical Medicine
  53. Polylactide-Based Reactive Micelles as a Robust Platform for mRNA Delivery
    Céline Lacroix, Almudena Humanes, Céline Coiffier, Didier Gigmès, Bernard Verrier, Thomas Trimaille · 2020 · Pharmaceutical Research
  54. Humanized Mice for Infectious and Neurodegenerative disorders
    Prasanta Kumar Dash, Santhi Gorantla, Larisa Y. Poluektova, Mahmudul Hasan, Emiko M. Waight, Chen Zhang, Milica Marković, Benson Edagwa, Jatin Machhi, Katherine E. Olson et al. · 2021 · Retrovirology
  55. Lipid nanoparticle delivery of unmodified mRNAs encoding multiple monoclonal antibodies targeting poxviruses in rabbits
    Eric M. Mucker, Carolin Thiele-Suess, Patrick Baumhof, Jay W. Hooper · 2022 · Molecular Therapy — Nucleic Acids
  56. Recent Progress in the Discovery and Development of Monoclonal Antibodies against Viral Infections
    Pardis Mokhtary, Zeinab Pourhashem, Akram Abouie Mehrizi, Claudia Sala, Rino Rappuoli · 2022 · Biomedicines
  57. Preclinical characterization of an mRNA-encoded anti-Claudin 18.2 antibody
    Hayat Bähr-Mahmud, Ursula Ellinghaus, Christiane Stadler, Leyla Fischer, Claudia Lindemann, Anuhar Chaturvedi, Jan Diekmann, Stefan Wöll, Imke Biermann, Bernhard Hebich et al. · 2023 · OncoImmunology
  58. Rational design of lipid nanoparticles for enabling gene therapies
    Cedric A. Brimacombe, Jayesh A. Kulkarni, Miffy H. Y. Cheng, Kevin An, Dominik Witzigmann, Pieter R. Cullis · 2025 · Molecular Therapy — Methods & Clinical Development
  59. mRNA vaccine platforms: linking infectious disease prevention and cancer immunotherapy
    Dariush Haghmorad, Majid Eslami, Niloufar Orooji, Iryna Halabitska, Iryna Ivanivna Kamyshna, Oleksandr Kamyshnyi, Valentyn Oksenych · 2025 · Frontiers in Bioengineering and Biotechnology
  60. mRNA delivery via non-viral carriers for biomedical applications
    Qi Shuai, Fangtao Zhu, Mengdan Zhao, Yunfeng Yan · 2021 · International Journal of Pharmaceutics
  61. Therapeutic advances in Fabry disease: The future awaits
    Sam Kant, Mohamed G. Atta · 2020 · Biomedicine & Pharmacotherapy
  62. Synthesis of point-modified mRNA
    Jasmin Hertler, Kaouthar Slama, Benedikt Schober, Zeynep Özrendeci, Virginie Marchand, Yuri Motorin, Mark Helm · 2022 · Nucleic Acids Research
  63. Nanovaccines against Viral Infectious Diseases
    Wen Tzuen Heng, Jia Sheng Yew, Chit Laa Poh · 2022 · Pharmaceutics
  64. Sustained release of PKR inhibitor C16 from mesoporous silica nanoparticles significantly enhances mRNA translation and anti-tumor vaccination
    Wei Zhang, Yi Liu, Jas Min Chin, Kyle K.L. Phua · 2021 · European Journal of Pharmaceutics and Biopharmaceutics
  65. Engineered mRNA-expressed bispecific antibody prevent intestinal cancer via lipid nanoparticle delivery
    Lipei Wu, Weiwei Wang, Jiale Tian, Chunrun Qi, Zhengxin Cai, Wenhui Yan, Shihai Xuan, Anquan Shang · 2021 · Bioengineered
  66. mRNA-based vaccine technology for HIV
    Albert-Ludwigs-Universität Freiburg, Germany, Andra Fortner, Octavian Bucur · 2022 · Discoveries
  67. Innovations in HIV-1 Vaccine Design
    Letitia D. Jones, Michael Anthony Moody, Amelia B. Thompson · 2020 · Clinical Therapeutics
  68. Intranasal delivery of replicating mRNA encoding neutralizing antibody against SARS-CoV-2 infection in mice
    Jiaqi Li, Zherui Zhang, Hong-Qing Zhang, Yanan Zhang, Xiang‐Yue Zeng, Qiu‐Yan Zhang, Cheng‐Lin Deng, Xiaodan Li, Bo Zhang, Han‐Qing Ye · 2021 · Signal Transduction and Targeted Therapy
  69. Lipid-Based Delivery Systems in Development of Genetic and Subunit Vaccines
    Azam Bolhassani · 2022 · Molecular Biotechnology
  70. Expanding the Reach of Monoclonal Antibodies: A Review of Synthetic Nucleic Acid Delivery in Immunotherapy
    Christopher W. Chung, Sagar B. Kudchodkar, Curtis N. Chung, Young K. Park, Ziyang Xu, Norbert Pardi, Mohamed Abdel‐Mohsen, Kar Muthumani · 2023 · Antibodies
  71. Antibody-based therapeutic interventions: possible strategy to counter chikungunya viral infection
    Rajesh Kumar, Tripti Shrivastava, Sweety Samal, Shubbir Ahmed, Hilal Ahmad Parray · 2020 · Applied Microbiology and Biotechnology
  72. An Inside Job: Applications of Intracellular Single Domain Antibodies
    Eline Soetens, Marlies Ballegeer, Xavier Saelens · 2020 · Biomolecules
  73. mRNA-Based Vaccines and Mode of Action
    Janina Gergen, Benjamin Petsch · 2020 · Current topics in microbiology and immunology
  74. Reappraisal of PRRS Immune Control Strategies: The Way Forward
    Massimo Amadori, Elisabetta Razzuoli, Valeria Listorti · 2021 · Pathogens
  75. Correction of bleeding in experimental severe hemophilia A by systemic delivery of factor VIII-encoding mRNA
    Jules Russick, Sandrine Delignat, Peter Milanov, Olivier D. Christophe, Gábor Boros, Cécile V. Denis, Peter J. Lenting, Srini V. Kaveri, Sébastien Lacroix‐Desmazes · 2019 · Haematologica
  76. Intracranial delivery of synthetic mRNA to suppress glioblastoma
    Peng, Hao, Guo, Xingrong, He, Jinjuan, Duan, Chao, Yang, Minghuan, Zhang, Xianghua, Zhang, Li, Fu, Rui, Wang, Bin, Wang, Dekang et al. · 2022 · Molecular Therapy - Oncolytics
  77. Advances in mRNA-based drug discovery in cancer immunotherapy
    Claudia Augusta Di Trani, Myriam Fernández-Sendin, Assunta Cirella, Aina Segués, Irene Olivera, Elixabet Bolaños, Ignacio Melero, Pedro Berraondo · 2021 · Expert Opinion on Drug Discovery
  78. Have mRNA vaccines sentenced DNA vaccines to death?
    Alberto Cagigi, Bruno G. Douradinha · 2023 · Expert Review of Vaccines
  79. Humanized Mice for the Evaluation of Novel HIV-1 Therapies
    Shawn A. Abeynaike, Silke Paust · 2021 · Frontiers in Immunology
  80. Strategies to deliver RNA by nanoparticles for therapeutic potential
    Alysia Cox, Siyoung A. Lim, Eun Ji Chung · 2021 · Molecular Aspects of Medicine
  81. Nanobodies – Little helpers unravelling intracellular signaling
    Teresa R. Wagner, Ulrich Rothbauer · 2021 · Free Radical Biology and Medicine
  82. M 3 RNA Drives Targeted Gene Delivery in Acute Myocardial Infarction
    Raman Deep Singh, Matthew L. Hillestad, Christopher Livia, Mark Li, Alexey E. Alekseev, Tyra A. Witt, Paul G. Stalboerger, Satsuki Yamada, André Terzic, Atta Behfar · 2018 · Tissue Engineering Part A
  83. Advancing mRNA technologies for therapies and vaccines: An African context
    Kairuz, Dylan, Samudh, Nazia, Ely, Abdullah, Arbuthnot, Patrick, Bloom, Kristie · 2022 · Frontiers in Immunology
  84. mRNA-based HIV-1 vaccines
    Shamim Ahmed, Alon Herschhorn · 2024 · Clinical Microbiology Reviews
  85. Impact of tail unsaturation in ionizable lipids on mRNA delivery efficiency and immunogenicity of lipid nanoparticles
    Xueer Ge, Zepeng He, Haihong Yang, Xiaorong Pan, Liang Yan, Yi Shi, Yongming Chen, Zhijia Liu · 2025 · Journal of Controlled Release
  86. RNA Therapeutics: A Healthcare Paradigm Shift
    Sarfaraz K. Niazi · 2023 · Biomedicines
  87. In-Vivo Gene Therapy with Foamy Virus Vectors
    Yogendra Singh Rajawat, Olivier Humbert, Hans‐Peter Kiem · 2019 · Viruses
  88. The mRNA-1647 vaccine: A promising step toward the prevention of cytomegalovirus infection (CMV)
    Adewunmi Akingbola, Abiodun Adegbesan, Olajumoke Adesola Adewole · 2025 · Human Vaccines & Immunotherapeutics
  89. In the Era of mRNA Vaccines, Is There Any Hope for HIV Functional Cure?
    Ignasi Esteban, Carmen Pastor-Quiñones, Lorena Usero, Montserrat Plana, Felipe García, Lorna Leal · 2021 · Viruses
  90. Humanized mouse models to study pathophysiology and treatment of HIV infection
    Guillemette Masse‐Ranson, Hugo Mouquet, James P. Di Santo · 2017 · Current Opinion in HIV and AIDS
  91. Platforms Exploited for SARS-CoV-2 Vaccine Development
    Shilu Mathew, Muhammed Faheem, Neeraja A. Hassain, Fatiha M. Benslimane, Asmaa A. Al Thani, Hassan Zaraket, Hadi Mohamad Yassine · 2020 · Vaccines
  92. Vaccines against COVID-19: Priority to mRNA-Based Formulations
    Steve Pascolo · 2021 · Cells
  93. Targeting the Inside of Cells with Biologicals: Chemicals as a Delivery Strategy
    Andrea L. J. Marschall · 2021 · BioDrugs
  94. mRNA treatment produces sustained expression of enzymatically active human ADAMTS13 in mice
    Liu-Chen, Susan, Connolly, Brendan, Cheng, Lei, Subramanian, Romesh R., Han, Zhaozhong · 2018 · Scientific Reports
  95. In Vivo Electroporation of Plasmid DNA: A Promising Strategy for Rapid, Inexpensive, and Flexible Delivery of Anti-Viral Monoclonal Antibodies
    Silvère Pagant, Rachel A. Liberatore · 2021 · Pharmaceutics
  96. Intracellular Delivery of mRNA for Cell‐Selective CRISPR/Cas9 Genome Editing using Lipid Nanoparticles
    Tianyu Ma, Xianghan Chen, Ming Wang · 2023 · ChemBioChem
  97. Comprehensive evaluation of T7 promoter for enhanced yield and quality in mRNA production
    Yustika Sari, Sara Sousa Rosa, Jack W. E. Jeffries, Marco P. C. Marques · 2024 · Scientific Reports
  98. The Potential of Nanomedicine to Unlock the Limitless Applications of mRNA
    Laura Taina-González, María de la Fuente · 2022 · Pharmaceutics
  99. Current knowledge on the tissue distribution of mRNA nanocarriers for therapeutic protein expression
    Matthias Zadory, Elliot Lopez, Samuel Babity, Simon‐Pierre Gravel, Davide Brambilla · 2022 · Biomaterials Science
  100. Vaccine innovations for emerging infectious diseases—a symposium report
    Jennifer Cable, Padmini Srikantiah, James E. Crowe, Bali Pulendran, Adrian V. S. Hill, Ann M. Ginsberg, Wayne Chester Koff, Anuja Mathew, Tony W. Ng, Kathrin Ute Jansen et al. · 2019 · Annals of the New York Academy of Sciences